Dr. Efrem H. Zaret
Instructor Dr. Efrem H. Zaret
Product Id 600721
Duration 60 Minutes  
Version Recorded
Original Price $295
Special Offer Price $10
Refund Policy
Access recorded version only for one participant; unlimited viewing for 6 months

GMP Compliance for Dietary Supplements


The U.S. Food and Drug Administration issued the final rule establishing regulations to require current good manufacturing practices (CGMPs) for dietary supplements.

The current good manufacturing practices (CGMPs) final rule will require that proper controls are in place for dietary supplements so that they are processed in a consistent manner, and meet quality standards. The CGMPs apply to all domestic and foreign companies that manufacture, package, label or hold dietary supplements, including those involved with the activities of testing, quality control, packaging and labeling, and distributing them in the U.S. The rule establishes CGMPs for industry-wide use that are necessary to require that dietary supplements are manufactured consistently as to identity, purity, strength, and composition. The requirements include provisions related to: the design and construction of physical plants that facilitate maintenance, cleaning, proper manufacturing operations, quality control procedures, testing final product or incoming and inprocess materials, handling consumer complaints, and maintaining records.

Dietary Supplement manufacturing sites have been increasingly inspected by the FDA for compliance with the GMPs, and warning letters have been issued.  In the face of the increasing scrutiny by the FDA, it is incumbent on dietary supplement manufacturers to understand the regulations and to implement documentation and procedures that will ensure compliance.

Why should you attend:
The regulations require that you understand the requirements and establish a Quality System designed to meet them. This presentation will review the requirements and the rationale for them.

Areas Covered in the Session:

  • History of the regulations and their current status
  • Review of the key points of the regulations
  • Discussion of methods that can be used to comply with the regulations
  • Documentation that is required for compliance
  • The role of the Quality organization
  • What to expect during an FDA inspection
  • How to respond to an FDA inspection
  • Raw material control and incoming inspection
  • Cleaning and Maintenance
Who Will Benefit:
  • Senior Management
  • Quality Control Management and personnel
  • Manufacturing management and supervisors
  • Warehouse Management and supervisors
  • Shipping and Distribution Management and supervisors

Speaker Profile
Dr. Efrem Zaret, President of EZ Associates Inc., is actively engaged in consulting assignments involved with the Chemistry, Manufacturing, Control, and Quality of new and existing drug products, dietary supplements and active pharmaceutical ingredients and with the preparation and logistics of clinical supplies. He assists clients in the identification and control of contract service organizations, drug evaluation and testing, with the preparation and implementation of quality systems and with submissions to the FDA. He also does training on GMP principles and related topics.

Dr. Zaret has industrial experience in the development, manufacturing, packaging and evaluation of drugs, foods, nutritionals, and other regulated products both in the United States and in Europe. Dr. Zaret obtained his B.S. in Chemistry from the Illinois Institute of Technology and his M.S. and Ph.D. degrees in Organic Chemistry from the University of Wisconsin-Milwaukee.

Sign Up for Our Newsletter